Comparison of SARS-CoV-2 serological tests with different antigen targets

Alix T. Coste(Czech Academy of Sciences, Institute of Microbiology), Antony Croxatto(University of Lausanne), Matthaios Papadimitriou‐Olivgeris(University Hospital of Lausanne), Katia Jaton(University of Lausanne), Gilbert Greub(University of Lausanne)
Journal of Clinical Virology
November 17, 2020
10.1016/j.jcv.2020.104690
Cited by 81

Related Papers

Sepsis: a roadmap for future research
|The Lancet Infectious Diseases|2015|1k
Antifungal Resistance and New Strategies to Control Fungal Infections
|International Journal of Microbiology|2011|504
A Mutation in Tac1p, a Transcription Factor Regulating <i>CDR1</i> and <i>CDR2</i>, Is Coupled With Loss of Heterozygosity at Chromosome 5 to Mediate Antifungal Resistance in <i>Candida albicans</i>
|Genetics|2006|383
First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study
|American Journal of Transplantation|2020|134
Bacterial genome sequencing in clinical microbiology: a pathogen-oriented review
|European Journal of Clinical Microbiology & Infectious Diseases|2017|131